NAMS
NewAmsterdam Pharma Company N.V.
24.20$
-0.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | -1,424.1% | – | – | |
| – | +306.8% | +80.0% | +444.4% | +130.6% | +94.7% | |
| – | – | +230.9% | +496.8% | +36.8% | +76.8% | |
| – | -231.0% | – | – | – | – | |
| – | – | +132.1% | -43.4% | -657.0% | – | |
| – | +50.1% | +820.8% | -89.1% | +2,700.0% | -63.4% | |
| – | +50.1% | +820.8% | -89.1% | +261,766.7% | +178.3% | |
| – | -100.1% | – | -100.0% | – | – | |
| – | +508.4% | +362.7% | -97.7% | +7,300.2% | -95.5% | |
| – | +665.6% | +707.4% | -131.2% | – | -165.0% | |
| – | – | – | -1,452.4% | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.